127 related articles for article (PubMed ID: 16205100)
1. [Basic principles of signal transduction].
Yarden Y
Onkologie; 2005 Oct; 28 Suppl 4():14-7. PubMed ID: 16205100
[No Abstract] [Full Text] [Related]
2. [EGF receptor blockade with monoclonal antibodis and so-called "small molecules"].
Ciardiello F; Ma B
Onkologie; 2005 Oct; 28 Suppl 4():18-24. PubMed ID: 16205101
[No Abstract] [Full Text] [Related]
3. Targeted therapies: aiming for the bull's-eye.
Gaguski ME
ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
[No Abstract] [Full Text] [Related]
4. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
Lage A; Crombet T; González G
Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019
[TBL] [Abstract][Full Text] [Related]
5. Rational bases for the development of EGFR inhibitors for cancer treatment.
Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
[TBL] [Abstract][Full Text] [Related]
6. EGFR as a target: rationale for therapy.
Wujcik D
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):5-9. PubMed ID: 16616281
[TBL] [Abstract][Full Text] [Related]
7. [Recent topics on leukemia: New molecular targeting therapy].
Hirai H
Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1036-42. PubMed ID: 12866451
[No Abstract] [Full Text] [Related]
8. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
Lang A; Graeven U
Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
[No Abstract] [Full Text] [Related]
9. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.
Dassonville O; Bozec A; Fischel JL; Milano G
Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578
[TBL] [Abstract][Full Text] [Related]
10. [Value of inhibition of signal transduction and epigenetic therapy concepts in cancer therapy].
Tabernero J; Kaye S
Onkologie; 2005 Oct; 28 Suppl 4():43-7. PubMed ID: 16285040
[No Abstract] [Full Text] [Related]
11. [Future perspectives. From basic research to the development of new therapies aimed at the inhibition of the different stages of signal transduction: applications in breast cancer].
Campone M; Kerbrat P; Roché H; Bennouna J; Cuillière JC; Le Mevel B; Fumoleau P
Bull Cancer; 2003 Oct; 90(10):851-64. PubMed ID: 14706914
[TBL] [Abstract][Full Text] [Related]
12. [Cetuximab. A monoclonal antibody against the EGF receptor].
Wasielewski S
Med Monatsschr Pharm; 2004 Sep; 27(9):292-4. PubMed ID: 15490614
[No Abstract] [Full Text] [Related]
13. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
14. [Tyrosine kinase inhibitors. An approach to pathogenesis-oriented tumor therapy].
Alves F; Hiddemann W
Internist (Berl); 1997 Nov; 38(11):1074-82. PubMed ID: 9453957
[No Abstract] [Full Text] [Related]
15. [Clinical development of targeted moledular cancer drugs].
Zwierzina H; Borner M
Onkologie; 2005 Oct; 28 Suppl 4():35-9. PubMed ID: 16205104
[No Abstract] [Full Text] [Related]
16. Targeted therapies: a nursing perspective.
Kay P
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
Venook AP
Cancer; 2005 Jun; 103(12):2435-46. PubMed ID: 15880563
[TBL] [Abstract][Full Text] [Related]
18. SRC as a target for anti-cancer drugs.
Levitzki A
Anticancer Drug Des; 1996 Apr; 11(3):175-82. PubMed ID: 8663905
[No Abstract] [Full Text] [Related]
19. Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction.
Reins HA; Steinhilber G; Freiberg B; Anderer FA
J Cell Biochem; 1993 Feb; 51(2):236-48. PubMed ID: 8382707
[TBL] [Abstract][Full Text] [Related]
20. [New agents for solid tumours].
Raida M
Dtsch Med Wochenschr; 2006 Oct; 131(43):2407-10. PubMed ID: 17054057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
